cagrisema semaglutide cagrilintide phase 3 results 2024 2025 obesity Presenters to provide first look at data from REIMAGINE trials of cagrilintide/semaglutide for type 2 diabetes management Cagrilintide lowers bodyweight through brain

doi: 10.1111/j.1753-4887.2010.00352.x

I'm really happy with how it's working so far

Signaling cascades initiate

Jan 3, 2026 Dark circles under eyes create persistent cosmetic concern affecting appearance across all ages and skin types, with multiple underlying causes including thin periorbital skin revealing underlying vasculature, hyperpigmentation from melanin accumulation, shadows from volume loss and fat pad descent, and fluid retention creating puffiness accentuating darkness

Figure 4 Dihexa otoprotection is mediated by HGF/c-Met signaling We used the pharmacological inhibitor 6-AH to investigate if the observed protection conferred by Dihexa is actually mediated by HGF/c-Met signaling

Laboratory investigations continue to examine its potential interactions with skin elasticity, dermal architecture, pigmentation and age-related structural changes